{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:39:45Z","timestamp":1785577185592,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.rvsc.2017.03.016","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T11:28:26Z","timestamp":1490700506000},"page":"117-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pharmacokinetic\/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses"],"prefix":"10.1016","volume":"114","author":[{"given":"Juan Manuel","family":"Serrano-Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"G\u00f3mez-D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Esgueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Castej\u00f3n-Riber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mena-Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciano","family":"Priego-Capote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nah\u00fam","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel Serrano","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2017.03.016_bb0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jvim.12153","article-title":"Pharmacodynamic evaluation of 4 angiotensin-converting enzyme inhibitors in healthy adult horses","volume":"27","author":"Afonso","year":"2013","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0010","article-title":"Attenuation of the blood pressure response to exogenous angiotensin I after oral administration of benazepril to healthy adult horses","author":"Afonso","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2460\/ajvr.69.1.122","article-title":"Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis","volume":"69","author":"Bailey","year":"2008","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0020","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.rvsc.2011.10.011","article-title":"Association between circulating angiotensin-converting enzyme and exercise-induced pulmonary haemorrhage in thoroughbred racehorses","volume":"93","author":"Costa","year":"2012","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0025","series-title":"ADAPT 5 user's Guide: Pharmacokinetic\/Pharmacodynamic Systems Analysis Software","author":"D'Argenio","year":"2009"},{"key":"10.1016\/j.rvsc.2017.03.016_bb0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/evj.12206","article-title":"Effects of quinapril on angiotensin-converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses","volume":"46","author":"Davis","year":"2014","journal-title":"J. Equine Vet."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0035","first-page":"231","article-title":"Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses","volume":"18","author":"Gardner","year":"2004","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.rvsc.2007.11.002","article-title":"Aldosterone plasma concentration in horses with heart valve insufficiencies","volume":"85","author":"Gehlen","year":"2002","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.rvsc.2014.06.006","article-title":"Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses","volume":"97","author":"G\u00f3mez-D\u00edez","year":"2014","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tvjl.2015.10.024","article-title":"Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat after intravenous and oral doses of ramipril in healthy horses","volume":"208","author":"Serrano-Rodr\u00edguez","year":"2016","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2885.2003.00468.x","article-title":"Pharmacokinetic\u2044pharmacodynamic modelling of the disposition and effect of benazepril and benazeprilat in cats","volume":"26","author":"King","year":"2003","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2014.13","article-title":"Visualization and communication of pharmacometric models with Berkeley Madonna","volume":"3","author":"Krause","year":"2014","journal-title":"CPT Pharmacometrics & Systems Pharmacology"},{"key":"10.1016\/j.rvsc.2017.03.016_bb0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01071348","article-title":"Pharmacokinetics of an ACE inhibitor, S-9780, in man: evidence of tissue binding","volume":"17","author":"Lees","year":"1989","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1939-1676.2006.tb02888.x","article-title":"Pharmacokinetic and pharmacodynamic parameters of ramipril and ramiprilat in healthy dogs and dogs with reduced glomerular filtration rate","volume":"20","author":"Lef\u00e8bvre","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0075","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2174\/138161207780618830","article-title":"Angiotensin-converting enzyme inhibitors in veterinary medicine","volume":"13","author":"Lef\u00e8bvre","year":"2007","journal-title":"Curr. Pharm. Design"},{"key":"10.1016\/j.rvsc.2017.03.016_bb0080","series-title":"Equine Pharmacology","first-page":"3","article-title":"Horse of a different color: Peculiarities of equine pharmacology","author":"Maxwell","year":"2015"},{"key":"10.1016\/j.rvsc.2017.03.016_bb0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tvjl.2015.10.036","article-title":"Modulation of acute transient exercise-induced hypertension after oral administration of four angiotensin-converting enzyme inhibitor in normotensive horses","volume":"208","author":"Mu\u00f1oz","year":"2016","journal-title":"Vet. J."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2460\/javma.243.1.126","article-title":"Hypertensive cardiomyopathy in horses: 5 cases (1995\u20132011)","volume":"243","author":"Navas de Sol\u00eds","year":"2013","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0095","doi-asserted-by":"crossref","first-page":"E946","DOI":"10.1152\/ajpendo.2001.281.5.E946","article-title":"A nonlabeled method to evaluate cortisol production rate by modeling plasma CBG-free cortisol disposition","volume":"281","author":"Picard-Hagen","year":"2001","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0100","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2885.2004.00601.x","article-title":"Pharmacokinetic and pharmacokinetic\/pharmacodynamic relationships for angiotensin-converting enzyme inhibitors","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0105","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0022-3565(24)35393-5","article-title":"Benazeprilat disposition and effect in dogs revisited with a pharmacokinetic\/pharmacodynamics modeling approach","volume":"292","author":"Toutain","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.rvsc.2017.03.016_bb0110","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1365\/s10337-008-0757-5","article-title":"Simultaneous determination of ramipril and its active metabolite ramiprilat in human plasma by LC\u2013MS-MS","volume":"68","author":"Yuan","year":"2008","journal-title":"Chromatographia"},{"key":"10.1016\/j.rvsc.2017.03.016_bb0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The heart outcomes prevention evaluation study investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N. Engl. J. Med."}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003452881730351X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003452881730351X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:13:09Z","timestamp":1758514389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003452881730351X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":23,"alternative-id":["S003452881730351X"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2017.03.016","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic\/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2017.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}